This is obviously good, but I will note:<p><i>Although doctors can read any patient’s DNA today, interpreting the results to understand how a patient will respond to cancer treatment is much more challenging</i><p>and<p><i>My team and I have started two clinical trials to expand the results of our previous studies on providing treatment recommendations through functional precision medicine. We’re recruiting a larger cohort of adults and children with cancers that have come back or are resistant to treatment.</i><p>Right now, as far as I can tell, no company is the equivalent of CARIS (<a href="https://www.carislifesciences.com/" rel="nofollow">https://www.carislifesciences.com/</a>) in molecular profiling, or Natera in circulating-tumor DNA: <a href="https://www.natera.com/" rel="nofollow">https://www.natera.com/</a>. My wife and I have been looking into companies that match tumors with treatments and not finding a lot. Just trying to find a company that'll do whole tumor sequencing is hard.<p>So while cancer patients "can now be 'matched,'" it's still, unless I'm missing something (always possible), quite hard to go from "I am a cancer patient" to "Here are some matches."